82 related articles for article (PubMed ID: 2640065)
1. Damage to DNA strand and the effects of anticancer drugs.
Kanamaru R; Ishioka C; Konishi Y; Ishikawa A; Shibata H; Wakui A
Sci Rep Res Inst Tohoku Univ Med; 1989 Dec; 36(1-4):29-36. PubMed ID: 2640065
[TBL] [Abstract][Full Text] [Related]
2. [DNA damage and anticancer effect].
Kanamaru R; Ishioka C; Konishi Y; Ishikawa S; Shibata H; Wakui A
Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 2):517-23. PubMed ID: 2181939
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of DNA damage induced by nitrosourea derivatives in rat brain tumor cells using a sequencing procedure].
Mineura K; Fushimi S; Sasajima H; Sasaki J; Ishino Y; Kowada M
Gan To Kagaku Ryoho; 1988 Feb; 15(2):307-11. PubMed ID: 3422552
[TBL] [Abstract][Full Text] [Related]
4. Comparative studies on the action of 7-N-[2-[[2-(gamma-L-glutamylamino)ethyl]dithio]ethyl]mitomycin C and of mitomycin C on cultured HL-60 cells and isolated phage and plasmid DNA.
Ishioka C; Kanamaru R; Konishi Y; Ishikawa A; Shibata H; Wakui A
Cancer Chemother Pharmacol; 1990; 26(2):117-21. PubMed ID: 2112051
[TBL] [Abstract][Full Text] [Related]
5. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex.
Hofland K; Petersen BO; Falck J; Helin K; Jensen PB; Sehested M
Clin Cancer Res; 2000 Apr; 6(4):1488-97. PubMed ID: 10778981
[TBL] [Abstract][Full Text] [Related]
6. [Antitumor activity of a new nitrosourea, MCNU, on a cellular morphological basis evaluated by a new in vitro antitumor sensitivity assay].
Oguro M; Yanagawa T; Takenaga K
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2550-6. PubMed ID: 6594974
[TBL] [Abstract][Full Text] [Related]
7. [DNA damage induced by fotemustine in cultured HL60 cells].
Shou J; Feng XW
Zhongguo Yao Li Xue Bao; 1996 Sep; 17(5):474-7. PubMed ID: 9863179
[TBL] [Abstract][Full Text] [Related]
8. Production of protein-associated DNA breaks by 10-[diethylaminopropylamino]-6-methyl-5H-pyrido[3',4':4,5]pyrrolo [2,3-g]isoquinoline in cultured L1210 cells and in isolated nuclei: comparison with other topoisomerase II inhibitors.
Pierson V; Pierre A; Pommier Y; Gros P
Cancer Res; 1988 Mar; 48(6):1404-9. PubMed ID: 2830964
[TBL] [Abstract][Full Text] [Related]
9. [Enhancement of the effects of anticancer agents on B16 melanoma cells by combination with cepharanthine--II. Antimetabolite, alkylating agent, nitrosourea].
Kubota R; Kubota K; Yamada S
Gan To Kagaku Ryoho; 1992 Nov; 19(13):2169-74. PubMed ID: 1444482
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxicity, DNA strand breakage and DNA-protein crosslinking by a novel transplatinum compound in human A2780 ovarian and MCF-7 breast carcinoma cells.
Farrell N; Povirk LF; Dange Y; DeMasters G; Gupta MS; Kohlhagen G; Khan QA; Pommier Y; Gewirtz DA
Biochem Pharmacol; 2004 Sep; 68(5):857-66. PubMed ID: 15294448
[TBL] [Abstract][Full Text] [Related]
11. Cellular processing of platinum anticancer drugs.
Wang D; Lippard SJ
Nat Rev Drug Discov; 2005 Apr; 4(4):307-20. PubMed ID: 15789122
[TBL] [Abstract][Full Text] [Related]
12. [Anticancer drug induced sister chromatid exchange and correlation to cell survival in human brain tumor cells].
Aida T; Bodell WJ
No To Shinkei; 1987 Mar; 39(3):235-41. PubMed ID: 3472531
[TBL] [Abstract][Full Text] [Related]
13. Chemopotentiating effects of a novel NAD biosynthesis inhibitor, FK866, in combination with antineoplastic agents.
Pogrebniak A; Schemainda I; Azzam K; Pelka-Fleischer R; Nüssler V; Hasmann M
Eur J Med Res; 2006 Aug; 11(8):313-21. PubMed ID: 17052966
[TBL] [Abstract][Full Text] [Related]
14. Potentiation of vincristine and actinomycin D by a new synthetic imidazole anti-tumor agent YM534 active against human cancer cells and multidrug-resistant cells.
Sato S; Watanabe Y; Okamura K; Hamanaka R; Mori T; Kohno K; Kuwano M
Anticancer Drug Des; 1989 Aug; 4(2):125-35. PubMed ID: 2803461
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy-induced bystander effect in response to several chloroethylnitrosoureas: an origin independent of DNA damage?
Merle P; Morvan D; Caillaud D; Demidem A
Anticancer Res; 2008; 28(1A):21-7. PubMed ID: 18383820
[TBL] [Abstract][Full Text] [Related]
16. Investigation of resistance to DNA cross-linking agents in 9L cell lines with different sensitivities to chloroethylnitrosoureas.
Bodell WJ; Gerosa M; Aida T; Berger MS; Rosenblum ML
Cancer Res; 1985 Aug; 45(8):3460-4. PubMed ID: 3860285
[TBL] [Abstract][Full Text] [Related]
17. Modeling anticancer drug-DNA interactions via mixed QM/MM molecular dynamics simulations.
Spiegel K; Magistrato A
Org Biomol Chem; 2006 Jul; 4(13):2507-17. PubMed ID: 16791311
[TBL] [Abstract][Full Text] [Related]
18. Differential scanning calorimetry of nuclei as a test for the effects of anticancer drugs on human chromatin.
Almagor M; Cole RD
Cancer Res; 1989 Oct; 49(20):5561-6. PubMed ID: 2477145
[TBL] [Abstract][Full Text] [Related]
19. DNA damage in cultured L1210 cells by 2-haloethyl esters of (methylsulfonyl)methanesulfonic acid.
Alexander JA; Bowdon BJ; Wheeler GP
Cancer Res; 1986 Dec; 46(12 Pt 1):6024-8. PubMed ID: 3022914
[TBL] [Abstract][Full Text] [Related]
20. DNA damage-processing pathways involved in the eukaryotic cellular response to anticancer DNA cross-linking drugs.
Beljanski V; Marzilli LG; Doetsch PW
Mol Pharmacol; 2004 Jun; 65(6):1496-506. PubMed ID: 15155842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
